News

Business Insider1y
Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases
Collaboration combines Intellia’s leading genome editing platform, including its proprietary Nme2Cas9 technology, with Regeneron’s proprietary ant ...
Yahoo Finance1mon
23andMe to be acquired by Regeneron
It also aligns with a strategy that 23andMe had been pursuing for years. The Regeneron Biotechnology company logo is seen displayed on a smartphone. (Igor Golovniov/SOPA Images/LightRocket via ...
Business Insider1y
Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases
Collaboration combines Intellia’s leading genome editing platform, including its proprietary Nme2Cas9 technology, with Regeneron’s proprietary antibody-targeted viral vector delivery ...